stoxline Quote Chart Rank Option Currency Glossary
  
Vogenx Inc. (VOGX)
13.78  -0.6 (-4.17%)    11-17 13:00
Open: 14.71
High: 14.71
Volume: 49,835
  
Pre. Close: 14.38
Low: 13.04
Market Cap: 205(M)
Technical analysis
2026-11-17 12:51:11 PM
Short term     
Mid term     
Targets 6-month :  21.67 1-year :  25.97
Resists First :  18.56 Second :  22.23
Pivot price 18.53
Supports First :  12.6 Second :  10.49
MAs MA(5) :  16.93 MA(20) :  18.57
MA(100) :  0 MA(250) :  0
MACD MACD :  -1.2 Signal :  -0.8
%K %D K(14,3) :  18.1 D(3) :  35.9
RSI RSI(14): 34.2
52-week High :  38.4 Low :  12.6
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ VOGX ] has closed below the lower bollinger band by 7.4%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ VOGX ] is to continue within current trading range. Bollinger Bands are 0% narrower than normal.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 16.75 - 16.85 16.85 - 16.92
Low: 12.42 - 12.53 12.53 - 12.6
Close: 14.23 - 14.4 14.4 - 14.53
Company Description

Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. The company's lead product candidate is mizagliflozin, an orally administered, small molecule drug candidate being developed for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome.

Headline News

Mon, 16 Nov 2026
Two firms report holding more than 5% of Vogenx (VOGX) on behalf of others. - Stock Titan

Mon, 16 Nov 2026
Options on 91,667 shares factor into a reported ownership stake in Vogenx (VOGX). - Stock Titan

Fri, 06 Nov 2026
Vogenx Reports $4.9 Million Quarterly Net Loss and $82.1 Million in Cash - TradingView

Fri, 06 Nov 2026
Vogenx (VOGX) Q3 Net Loss Widens to $4.9M - TradingView

Sun, 16 Aug 2026
Vogenx IPO Raises $81M for Trial in Metabolic Disease With No Approved Drugs - MedCity News

Thu, 13 Aug 2026
Vogenx Inc Common Stock (VOGX) News Headlines - Nasdaq

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 15 (M)
Shares Float 10 (M)
Held by Insiders 4.7 (%)
Held by Institutions 14 (%)
Shares Short 38 (K)
Shares Short P.Month 26 (K)
Stock Financials
EPS -0.22
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.35
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow -1 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio -62.28
PEG Ratio 0
Price to Book value -40.3
Price to Sales 0
Price to Cash Flow -236.07
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

Stoxline iOS

Alpha Bridge iOS

OptionCalc iOS

StockChart Android

Stoxline Android

Alpha Bridge Android

OptionCalc Android